## Abstract Alzheimer's disease (AD) affects millions of people worldwide and the number of AD cases will increase with increased life expectancy. Today there is no cure for this devastating and always lethal disease and therefore it is of great interest for patients, relatives and societies to fin
✦ LIBER ✦
Biomarkers for Alzheimer’s disease trials — biomarkers for what? A discussion paper
✍ Scribed by S. Lovestone; M. Thambisetty
- Book ID
- 107669801
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 137 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1279-7707
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Biomarkers for apoptosis in Alzheimer's
✍
Maria Ankarcrona; Bengt Winblad
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 85 KB
Cerebrospinal fluid proteomic biomarkers
✍
Erin J. Finehout; Zsofia Franck; Leila H. Choe; Norman Relkin; Kelvin H. Lee
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 673 KB
Proteomic discovery of CSF biomarkers fo
✍
Jing Zhang; Thomas J. Montine
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 39 KB
👁 2 views
Reply: Cerebrospinal fluid proteomics fo
✍
Kelvin H. Lee; Norman R. Relkin
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 44 KB
👁 2 views
Structural MRI biomarkers for preclinica
✍
Christine Fennema-Notestine; Donald J. Hagler Jr.; Linda K. McEvoy; Adam S. Flei
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 535 KB
## Abstract Noninvasive MRI biomarkers for Alzheimer's disease (AD) may enable earlier clinical diagnosis and the monitoring of therapeutic effectiveness. To assess potential neuroimaging biomarkers, the Alzheimer's Disease Neuroimaging Initiative is following normal controls (NC) and individuals w
Are advanced glycation end-products spec
✍
M. Staniszewska; J. Leszek; K. Małyszczak; A. Gamian
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 38 KB
👁 1 views